- Home
- BHC
as 11-21-2024 4:00pm EST
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | QUEBEC |
| Market Cap: | 3.0B | IPO Year: | N/A |
| Target Price: | $7.25 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.96 - $11.46 | Next Earning Date: | 10-30-2024 |
| Revenue: | $9,474,000,000 | Revenue Growth: | 10.91% |
| Revenue Growth (this year): | 9.59% | Revenue Growth (next year): | 3.53% |
Stock Insider Trading Activity of Bausch Health Companies Inc. (BHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Carson Seana | BHC | EVP, General Counsel | Sep 5 '24 | Sell | $6.21 | 13,370 | $83,027.70 | 435,198 |
Latest Bausch Health Companies Inc. News
BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
Bausch Health Canada Receives Reimbursement Recommendation for Acne Treatment
MT Newswires
4 days ago
Bausch Acne Gel Gets Reimbursement Nods from Canada's Drug Agency and Quebec's INESSS
ACCESSWIRE
4 days ago
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
ACCESSWIRE
4 days ago
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Zacks
16 days ago
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
Zacks
18 days ago
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term
MT Newswires
20 days ago
RBC on Bausch Health's Q3
Zacks
20 days ago
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
Compare BHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHC Bausch Health Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.